Growth DisordersNCT05841264
Growth Chart Parameters, Risk Factors
An observational study of Growth Disorders, run by Assiut University.
Trial summary
comparison between growth chart parameters and different risk factors which can cause abnormal growth chart parameter Read more about this study
- Who is it for?
- Ages 1 year to 5 yearsHealthy volunteers can take part
- Conditions the study is for
- Growth Disorders
- What is being tested?
- good feeding, cleaning
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 600 participants
- Where
- No sites listed yet
- Study dates
- 1 Jun 2023to 1 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year to 5 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: children living in different areas have low incomes, high fertility, and provide poor care form their parents different socioeconomic state, different type of food
Who may be able to join
- All children attending primary health care units in Assiut governorate aged from one year to five year
Who cannot join
- 1. congenital anomalies 2. chronic diseases (D.M , thyroid dysfunction)
About this study
Official title: Comparison Between Children Growth Chart Parameters and Their Abnormality Associated Risk Factors in Assiut Governorate
comparison between growth chart parameters and different risk factors which can cause abnormal growth chart parameter
Read the detailed description
Infant growth is defined as a positive change in body size over a period of time, and it is a sensitive predictor of an individuals' health. An inappropriate growth pattern indicates nutritional disorders, chronic and infectious diseases in infants. Early growth rate is related to adulthood health, such that it is important to develop the concept of appropriate growth for parents, in other to detect children with abnormal growth rates, as soon as possible .Weight and height of preschool children are the most common anthropometric measurements, to investigate a child's growth rate. Weight is the simplest and most reliable anthropometric measurement, and may be used as an indicator of childhood infection. On the other hand, height summarizes various measures of nutritional conditions in the first two decades of a human's life. Many children younger than 5 years in developing countries are exposed to multiple risks, including poverty, malnutrition, poor health, and unstimulating home environments, which detrimentally affect their cognitive, motor, and social-emotional development.
- Conditions
- Growth Disorders
- Being tested
- good feeding, cleaning
- Medical subject headings
- Growth Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
good feeding, cleaningBehavioural
taking healthy food which contain minerals, vitamins essential for normal growth
| Study group | Role | What they receive |
|---|---|---|
| children's in urban area | children's in this have good socioeconomic state, small family number, good hygiene Receives: Behavioral: good feeding, cleaning | |
| children in rural area | children's in this have bad socioeconomic state, large family number, bad hygiene Receives: Behavioral: good feeding, cleaning | |
| children in semi urban area | children's in this have bad socioeconomic state, small family number, bad hygiene Receives: Behavioral: good feeding, cleaning |
What is being measured
The primary outcome is the main question the study is designed to answer.
comparison of growth and development of children in different areas in Assiut governorate
by using WHO growth chart for weight and height parameter, if child weight and height in normal average or not
Measured: through study completion, an average of 1 year
Secondary outcomes (1)
factors affecting growth and development of children in different areas in Assiut governorate
questionnaire about different factors that can affect child growth
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 May 2023
- Study start1 Jun 2023 (estimated)
- Primary completion1 Dec 2024 (estimated)
- Study completion1 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Growth DisordersStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 600 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mariana Noss Abdo Abdelmalak, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05841264
- Sponsor's protocol ID
- Growth chart, Risk factors
- Status last verified
- Apr 2023
- First submitted
- 10 Apr 2023
- Last updated
- 3 May 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison Between Children Growth Chart Parameters and Their Abnormality Associated Risk Factors in Assiut Governorate
- ClinicalTrials.gov ID
- NCT05841264
- Acronym / sponsor ID
- Growth chart, Risk factors
- Conditions
- Growth Disorders
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 600 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Jun 2023 (estimated)
- Primary completion
- 1 Dec 2024 (estimated)
- Study completion
- 1 Jun 2025 (estimated)
- First posted
- 3 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
comparison between growth chart parameters and different risk factors which can cause abnormal growth chart parameter
Detailed description
Infant growth is defined as a positive change in body size over a period of time, and it is a sensitive predictor of an individuals' health. An inappropriate growth pattern indicates nutritional disorders, chronic and infectious diseases in infants. Early growth rate is related to adulthood health, such that it is important to develop the concept of appropriate growth for parents, in other to detect children with abnormal growth rates, as soon as possible .Weight and height of preschool children are the most common anthropometric measurements, to investigate a child's growth rate. Weight is the simplest and most reliable anthropometric measurement, and may be used as an indicator of childhood infection. On the other hand, height summarizes various measures of nutritional conditions in the first two decades of a human's life. Many children younger than 5 years in developing countries are exposed to multiple risks, including poverty, malnutrition, poor health, and unstimulating home environments, which detrimentally affect their cognitive, motor, and social-emotional development.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| children's in urban area | – | Behavioral: good feeding, cleaningchildren's in this have good socioeconomic state, small family number, good hygiene |
| children in rural area | – | Behavioral: good feeding, cleaningchildren's in this have bad socioeconomic state, large family number, bad hygiene |
| children in semi urban area | – | Behavioral: good feeding, cleaningchildren's in this have bad socioeconomic state, small family number, bad hygiene |
Who may qualify
- Ages
- 1 year to 5 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- children living in different areas have low incomes, high fertility, and provide poor care form their parents different socioeconomic state, different type of food
Key inclusion criteria (1 listed)
- All children attending primary health care units in Assiut governorate aged from one year to five year
Key exclusion criteria (1 listed)
- 1. congenital anomalies 2. chronic diseases (D.M , thyroid dysfunction)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| good feeding, cleaningtaking healthy food which contain minerals, vitamins essential for normal growth | Behavioural | children in rural area, children in semi urban area, children's in urban area |
Primary outcome
comparison of growth and development of children in different areas in Assiut governorate
Time frame: through study completion, an average of 1 year
by using WHO growth chart for weight and height parameter, if child weight and height in normal average or not
1 secondary outcome
factors affecting growth and development of children in different areas in Assiut governorate
Time frame: through study completion, an average of 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2023.
- Individual participant dataSharing planned: Undecided
Related trials for Growth Disorders
Active, not recruitingPhase 3
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
Non-small Cell Lung Cancer (NSCLC)
RecruitingPhase 1
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Solid Tumor, Advanced Solid Tumor
Active, not recruitingPhase 3
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
Carcinoma, Non-Small-Cell Lung
RecruitingObservational study
Children s Growth and Behavior Study
Obesity, Eating Behaviors
Active, not recruitingPhase 3
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
Non-small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Growth Disorders, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 May 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
comparison of growth and development of children in different areas in Assiut governorate (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2023.